Fibroblast growth factor 2 inhibits myofibroblastic activation of valvular interstitial cells

Abstract excerpt

Heart valve disease is a growing problem worldwide. Though very common in older adults, the mechanisms behind the development of the disease aren't well understood, and at present the only therapeutic option is valve replacement. Valvular interstitial cells (VICs) may hold the answer. These cells can undergo pathological differentiation into contractile myofibroblasts or osteoblasts, leading to thickening and...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cardiac Valve Diseases and Treatments
• Share to Platelet Disorders and Treatments